Lonza Group (OTCMKTS:LZAGY) Shares Cross Below 50-Day Moving Average – Here’s What Happened

Shares of Lonza Group Ag (OTCMKTS:LZAGYGet Free Report) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $63.23 and traded as low as $61.39. Lonza Group shares last traded at $62.41, with a volume of 140,962 shares.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Lonza Group from a “strong sell” rating to a “hold” rating in a report on Wednesday, April 8th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

Get Our Latest Analysis on Lonza Group

Lonza Group Stock Performance

The company has a current ratio of 2.24, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. The business has a fifty day simple moving average of $63.23 and a 200 day simple moving average of $65.54.

About Lonza Group

(Get Free Report)

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.

Recommended Stories

Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.